Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.

Weaver JM, Lazarski CA, Richards KA, Chaves FA, Jenks SA, Menges PR, Sant AJ.

J Immunol. 2008 Sep 1;181(5):3039-48.

3.

The alloreactive and self-restricted CD4+ T cell response directed against a single MHC class II/peptide combination.

Kovalik JP, Singh N, Mendiratta SK, Martin WD, Ignatowicz L, Van Kaer L.

J Immunol. 2000 Aug 1;165(3):1285-93.

4.

Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Weaver JM, Sant AJ.

Immunol Res. 2009 Dec;45(2-3):123-43. doi: 10.1007/s12026-009-8095-8. Epub 2009 Feb 7. Review.

PMID:
19198764
5.

The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes.

Sant AJ, Chaves FA, Jenks SA, Richards KA, Menges P, Weaver JM, Lazarski CA.

Immunol Rev. 2005 Oct;207:261-78. Review.

PMID:
16181342
6.

Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.

Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V.

J Mol Recognit. 1993 Jun;6(2):81-94.

PMID:
7508238
7.

Extending the CD4(+) T-cell epitope specificity of the Th1 immune response to an antigen using a Salmonella enterica serovar typhimurium delivery vehicle.

Lo-Man R, Langeveld JP, Dériaud E, Jehanno M, Rojas M, Clément JM, Meloen RH, Hofnung M, Leclerc C.

Infect Immun. 2000 Jun;68(6):3079-89.

8.
9.
10.

The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.

Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, Weaver JM, Sant AJ.

Immunity. 2005 Jul;23(1):29-40.

11.

CD40/APC-specific antibodies with three T-cell epitopes loaded in the constant domains induce CD4+ T-cell responses.

Rasmussen IB, Oynebråten I, Høydahl LS, Flobakk M, Lunde E, Michaelsen TE, Bogen B, Sandlie I.

Protein Eng Des Sel. 2012 Mar;25(3):89-96. doi: 10.1093/protein/gzr063. Epub 2012 Jan 10.

PMID:
22233931
13.
14.

Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.

Karunakaran KP, Yu H, Jiang X, Chan Q, Moon KM, Foster LJ, Brunham RC.

Vaccine. 2015 Apr 27;33(18):2159-66. doi: 10.1016/j.vaccine.2015.02.055. Epub 2015 Mar 1.

16.

Mechanisms of T cell epitope immunodominance analyzed in murine listeriosis.

Safley SA, Jensen PE, Reay PA, Ziegler HK.

J Immunol. 1995 Nov 1;155(9):4355-66.

PMID:
7594595
17.

Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.

Kissick HT, Sanda MG, Dunn LK, Arredouani MS.

PLoS One. 2014 Apr 1;9(4):e93231. doi: 10.1371/journal.pone.0093231. eCollection 2014.

20.

The peptide specificity of the endogenous T follicular helper cell repertoire generated after protein immunization.

Leddon SA, Sant AJ.

PLoS One. 2012;7(10):e46952. doi: 10.1371/journal.pone.0046952. Epub 2012 Oct 15.

Supplemental Content

Support Center